Answers are grounded in this paper and cite their sources.
Corneal collagen CXL was found to be safe and effective in the first 12 months for keratoconus in children with similar initial efficacy as in adults in terms of improvement in visual and topographic outcomes.
No takes yet. Share an insight, caveat, or question.
Arora et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: